Ibuprofen, a weakly acidic non-steroidal anti-inflammatory drug having poor aqueous solubility, is a challenging drug for the development of pharmaceutical formulations, resulting in numerous research attempts focusing on improvement of its solubility and consequently bioavailability. Most studies have been done for solid dosage forms, with very little attention paid to parenterals. Hence, the main purpose of the present study was to enhance ibuprofen solubility as a result of formulation composition and the freeze drying process. Moreover, the purpose was to prepare a freeze dried dosage form with improved ibuprofen solubility that could, after simple reconstitution with water for injection, result in an isotonic parenteral solution. Solubility of ibuprofen was modified by various excipients suitable for parenteral application. Drug interactions with selected excipients in the final product/lyophilisate were studied by a combined use of XRPD, DSC, Raman and ss-NMR. Analyses of lyophilized samples showed solubility enhancement of ibuprofen and in situ formation of an ibuprofen salt with the alkaline excipients used.
If the inline PDF is not rendering correctly, you can download the PDF file here.
1. P. Khadka, J. Ro, H. Kim, I. Kim, J. T. Kim, H. Kim, J. M. Cho, G. Yun and J. Lee, Pharmaceutical particle technologies: An approach to improve drug solubility, dissolution and bioavailability, Asian J. Pharm. Sci.9 (2014) 304–316; https://doi.org/10.1016/j.ajps.2014.05.005
2. K. T. Savjani, A. Gajjar and J. K. Savjani, Drug solubility: Importance and enhancement techniques, International Scholarly Research Network, ISRN Pharm.12 (2012). Article ID 195727; http://dx.doi.org/10.5402/2012/195727
4. A. G. Martinez, B. E. Rodrigez, A. P. Roca and A. M. Ruiz, Intravenous ibuprofen for treatment of post-operative pain: A multicenter, double blind, placebo-controlled, randomized clinical trial, Plos One11 (2016) 1–16; https://doi.org/10.1371/journal.pone.0154004
5. J. Nerurkar, J. W. Beach, M. O. Park and H. W. Jun, Solubility of (±)-ibuprofen and S(+)-ibuprofen in the presence of cosolvents and cyclodextrins, Pharm. Dev. Technol.10 (2005) 413–421; https://doi.org/10.1081/PDT-54446
6. A. R. Fernandes, N. R. Ferreira, J. F. Fangueiro, A. C. Santos, F. J. Veiga, C. Cabral, A. M. Silva and E. B. Souto, Ibuprofen nanocrystals developed by 22 factorial design experiment: A new approach for poorly water-soluble drugs, Saudi Pharm. J.25 (2017) 1117–1124; https://doi.org/10.1016/j.jsps.2017.07.004
7. K. Stoyanova, Z. Vinarov and S. Tcholakova, Improving ibuprofen solubility by surfactant-facilitated self-assembly into mixed micelles, J. Drug. Deliv. Sci. Tec.36 (2016) 208–215; https://doi.org/10.1016/j.jddst.2016.10.011
8. A. Tan, N. G. Eskandar, S. Rao and C. A. Prestidge, First in man bioavailability and tolerability studies of a silica-lipid hybrid (Lipoceramic) formulation: A phase I study with ibuprofen, Drug. Deliv. Trans. Re.4 (2014) 212–221; https://doi.org/10.1007/s13346-013-0172-9
9. S. G. Potta, S. Minemi, R. K. Nukala, C. Peinado, D. A. Lamprou, A. Urquhart and D. Douroumis, Preparation and characterization of ibuprofen solid lipid nanoparticles with enhanced solubility, J. Microencapsul. 28 (2011) 74–81; http://doi.org/10.3109/02652048.2010.529948
10. S. Melzig, D. Niedbalka, C. Schilde and A. Kwade, Spray drying of amorphous ibuprofen nanoparticles for the production of granules with enhanced drug release, Colloids Surf. A Physicochem. Eng. Asp.536 (2018) 133–141; https://doi.org/10.1016/j.colsurfa.2017.07.028
11. D. Bolten, R. Lietzow and M. Türk, Solubility of ibuprofen, phytosterol, salicylic acid, and naproxen in aqueous solutions, Chem. Eng. Technol.36 (2013) 426–434; https://doi.org/10.1002/ceat.201200510
12. A. A. Mamun, A. Masum, F. Sharmin, A. Islam and S. Reza, Enhancement of solubility and dissolution characteristics of ibuprofen by solid dispersion technique, Dhaka University, J. Pharm. Sci.11 (2012) 1–6; https://doi.org/10.3329/dujps.v11i1.12480
13. M. M. Gupta, M. G. Patel, N. S. Patel and M. Kedawat, Enhancement of dissolution rate of ibuprofen by preparing solid dispersion using different methods, Int. J. Pharm. Pharm. Sci.3 (2011) 204–206.
14. R. P. Dugar, B. Y. Gajera and R. H. Dave, Fusion method for solubility and dissolution rate enhancement of ibuprofen using block copolymer poloxamer 407, AAPS PharmSciTech.17 (2016) 1428–1440; http://doi.ord/10.1208/s12249-016-0482-6
15. M. Dixit, P. Kulkarni, P. Selvam and S. Mohsin, Preparation and characterization of freeze dried crystals of ibuprofen, Int. Res. J. Pharm.2 (2011) 255–258.
16. Karsono, J. Tanuwijaya and D. Fatma, Formulation of ibuprofen orally disintegrating tablets (ODTs) by lyophilization method using gelatin and mannitol, Int. J. PharmTech. Res.6 (2014) 996–1002.
17. M. Di Cagno, P. C. Stein, N. Skalko-Basnet, M. Brandl and A. Bauer-Brandl, Solubilization of ibuprofen with β-cyclodextrin derivatives: Energetic and structural studies, J. Pharm. Biomed. Anal.55 (2011) 446–451; https://doi.org/10.1016/j.jpba.2011.02.022
18. K. Kagkadis, D. M. Rekkas, P. Dallas and N. H. Choulis, A freeze-dried injectable form of ibuprofen: development and optimisation using response surface methodology, PDA J. Pharm. Sci. Technol.50 (1996) 317–323; https://doi.org/10.1016/S0378-5173(97)00332-3
19. S. K. Patel, D. Kumar, A. P. Waghmode and A. S. Dhabale, Solubility enhancement of ibuprofen using hydrotopic agents, Int. J. Pharm. Life Sci.2 (2011) 542–545.
21. S. H. Soltanpour and A. Jouyban, Solubility of acetaminophen and ibuprofen in binary and ternary mixtures of polyethylene glycols 200 and 400, propylene glycol, and water at 25 °C, Chem. Eng. Commun.201 (2014) 1606–1619; https://doi.org/10.1080/00986445.2013.821609
22. M. A. Filippa and E. I. Gasull, Ibuprofen solubility in pure organic solvents and aqueous mixtures of cosolvents: Interactions and thermodynamic parameters relating to the solvation process, Fluid Phase Equilibr.354 (2013) 185–190; https://doi.org/10.1016/j.fluid.2013.06.032
23. M. G. Volonte, P. D. Valora, A. Cingolani and M. Ferrara, Stability of ibuprofen in injection solutions, Am. J. Health-Syst. Ph.62 (2005) 630–633.
30. J. N. Patel, D. M. Rathod, N. A. Patel and M. K. Modasiya, Techniques to improve the solubility of poorly soluble drugs, Int. J. Pharm. Life Sci.3 (2012) 1459–1469.
31. G. G. Z. Zhang, S. Y. L. Paspal, R. Suryanarayanan and D. J. W. Grant, Racemic species of sodium ibuprofen: Characterization and Polymorphic Relationships, J. Pharm. Sci.92 (2003) 1356–1366; https://doi.org/10.1002/jps.10393
32. J. C. Kasper and W. Friess, The freezing step in lyophilisation: Physico-chemical fundamentals, freezing methods and consequences on process performance and quality attributes of biopharmaceuticals, Eur. J. Pharmaceut. Biopharmaceut.78 (2011) 248–263; https://doi.org/10.1016/j.ejpb.2011.03.010
33. R. C. Rowe, P. J. Sheskey and M. E. Quinn, Mannitol, Sodium chloride, Dextrose and Succrose, in Handbook of Pharmaceutical Excipients (Ed. R. C. Rowe), 6th ed., Pharmaceutical Press and American Pharmacists Association, London/Washington, UK/USA 2009, pp. 426, 641, 224 and 704.
35. M. Geppi, S. Guccione, G. Mollica, R. Pignatello and C. Veracini, Molecular properties of ibuprofen and its solid dispersions with eudragit RL100 studied by solid state nuclear magnetic resonance, Pharm. Res. 22 (2005) 1544–1555; https://doi.org/10.1007/s11095-005-6249-5
38. T. Kitak, A. Dumičić, O. Planinšek, R. Šibanc and S. Srčič, Determination of solubility parameters of ibuprofen and ibuprofen lysinate, Molecules20 (2015) 21549–21568; https://doi.org/10.3390/molecules201219777
39. P. Bustamante, M. A. Peña and J. Barra, The modified extended Hansen method to determine partial solubility parameters of drug containing a single hydrogen bonding group and their sodium derivatives: benzoic acid/Na and ibuprofen/Na, Int. J. Pharm.194 (2000) 117–124; https://doi.org/10.1016/S0378-5173(99)00374-9